Bank of America’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-371
| Closed | -$931 | – | 7152 |
|
|
2023
Q1 | $931 | Sell |
371
-1,578
| -81% | -$3.96K | ﹤0.01% | 6480 |
|
|
2022
Q4 | $3.55K | Buy |
1,949
+498
| +34% | +$906 | ﹤0.01% | 6302 |
|
|
2022
Q3 | $10K | Sell |
1,451
-1
| -0.1% | -$7 | ﹤0.01% | 6381 |
|
|
2022
Q2 | $16K | Sell |
1,452
-3
| -0.2% | -$33 | ﹤0.01% | 6440 |
|
|
2022
Q1 | $32K | Buy |
1,455
+1,024
| +238% | +$22.5K | ﹤0.01% | 6549 |
|
|
2021
Q4 | $12K | Buy |
431
+279
| +184% | +$7.77K | ﹤0.01% | 6799 |
|
|
2021
Q3 | $9K | Buy |
152
+129
| +561% | +$7.64K | ﹤0.01% | 6702 |
|
|
2021
Q2 | $2K | Sell |
23
-919
| -98% | -$79.9K | ﹤0.01% | 6746 |
|
|
2021
Q1 | $125K | Buy |
942
+689
| +272% | +$91.4K | ﹤0.01% | 5628 |
|
|
2020
Q4 | $40K | Buy |
253
+122
| +93% | +$19.3K | ﹤0.01% | 5644 |
|
|
2020
Q3 | $14K | Sell |
131
-71
| -35% | -$7.59K | ﹤0.01% | 5706 |
|
|
2020
Q2 | $24K | Buy |
202
+50
| +33% | +$5.94K | ﹤0.01% | 5633 |
|
|
2020
Q1 | $12K | Sell |
152
-296
| -66% | -$23.4K | ﹤0.01% | 5701 |
|
|
2019
Q4 | $132K | Buy |
448
+222
| +98% | +$65.4K | ﹤0.01% | 5061 |
|
|
2019
Q3 | $41K | Buy |
226
+84
| +59% | +$15.2K | ﹤0.01% | 5552 |
|
|
2019
Q2 | $57K | Buy |
142
+27
| +23% | +$10.8K | ﹤0.01% | 5484 |
|
|
2019
Q1 | $54K | Sell |
115
-240
| -68% | -$113K | ﹤0.01% | 5406 |
|
|
2018
Q4 | $171K | Buy |
355
+246
| +226% | +$118K | ﹤0.01% | 4899 |
|
|
2018
Q3 | $74K | Hold |
109
| – | – | ﹤0.01% | 5299 |
|
|
2018
Q2 | $74K | Buy |
+109
| New | +$74K | ﹤0.01% | 5221 |
|